title: Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML.
authors.forename: A
authors.initials: A
authors.lastname: van der Jagt
authors.forename: J
authors.initials: J
authors.lastname: Muirhead
authors.forename: J F
authors.initials: JF
authors.lastname: Seymour
authors.forename: K F
authors.initials: KF
authors.lastname: Bradstock
authors.forename: E
authors.initials: E
authors.lastname: Paul
authors.forename: A
authors.initials: A
authors.lastname: Wei
mesh_terms: D000328:Adult; D003561:Cytarabine / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D016016:Proportional Hazards Models; D012307:Risk Factors
chemical_list: D003561:Cytarabine